Tam CF, Cheung KS, Lam S, Wong A, Yung A, Sze M, et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes. 2020;13:e006631. https://doi.org/10.1161/CIRCOUTCOMES.120.006631.
Mahmud E, Dauerman HL, Welt FGP, Messenger JC, Rao SV, Grines C, et al. Management of acute myocardial infarction during the COVID-19 pandemic: a position statement from the society for cardiovascular angiography and interventions (SCAI), the American college of cardiology (ACC), and the American college of emergency physicians (ACEP). J Am Coll Cardiol. 2020;76:1375–84.
Article CAS PubMed PubMed Central Google Scholar
Ikari Y, Yamada S, Ehara N, Kozuma K, Shinke T, Sugano T, et al. The Japanese association of cardiovascular intervention and therapeutics position statement on coronary invasive procedures during the COVID-19 pandemic in Japan. Cardiovasc Interv Ther. 2021;36:139–44.
Article CAS PubMed PubMed Central Google Scholar
Garcia S, Stanberry L, Schmidt C, Sharkey S, Megaly M, Albaghdadi MS, et al. Impact of COVID-19 pandemic on STEMI care: an expanded analysis from the United States. Catheter Cardiovasc Interv. 2021;98:217–22.
Terkelsen CJ, Lassen JF, Nørgaard BL, Gerdes JC, Poulsen SH, Bendix K, et al. Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutanous coronary intervention. Eur Heart J. 2005;26:770–7.
Diercks DB, Kontos MC, Chen AY, Pollack CV Jr, Wiviott SD, Rumsfeld JS, et al. Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (national cardiovascular data registry) ACTION (acute coronary treatment and intervention outcomes network) registry. J Am Coll Cardiol. 2009;53:161–6.
Mitarai T, Tanabe Y, Akashi YJ, Maeda A, Ako J, Ikari Y, et al. A novel risk stratification system “angiographic GRACE score” for predicting in-hospital mortality of patients with acute myocardial infarction: data from the K-ACTIVE registry. J Cardiol. 2021;77:179–85.
Nagumo S, Mori H, Maeda A, Akashi YJ, Ako J, Ikari Y, et al. Sex-related differences in in-hospital mortality in Japanese ST-elevation acute myocardial infarction patients presenting to hospital in the 24 hours after symptom onset - results from K-ACTIVE. Circ Rep. 2019;1:313–9.
Article PubMed PubMed Central Google Scholar
Mori H, Sakurai K, Ikari Y, Fukui K, Maeda A, Akashi Y, et al. Radial versus femoral access in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a propensity-matched analysis from real-world data of the K-ACTIVE registry. J Cardiol. 2023;81:189–95.
Ishii H, Amano T, Yamaji K, Kohsaka S, Yokoi H, Ikari Y. Implementation of percutaneous coronary intervention during the COVID-19 pandemic in Japan - nationwide survey report of the Japanese association of cardiovascular intervention and therapeutics for cardiovascular disease. Circ J. 2020;84:2185–9.
Article CAS PubMed Google Scholar
Ishii H, Amano T, Kohsaka S, Morino Y, Yokoi H, Ikari Y. National survey of percutaneous coronary intervention during the COVID-19 pandemic in Japan: second report of the Japanese association of cardiovascular intervention and therapeutics. Cardiovasc Interv Ther. 2022;37:264–8.
Article CAS PubMed Google Scholar
Ozaki Y, Tobe A, Onuma Y, Kobayashi Y, Amano T, Muramatsu T, et al. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024. Cardiovasc Interv Ther. 2024;39:335–75.
Article PubMed PubMed Central Google Scholar
Kobayashi S, Sakakura K, Jinnouchi H, Taniguchi Y, Tsukui T, Watanabe Y, et al. Comparison of door-to-balloon time and in-hospital outcomes in patients with ST-elevation myocardial infarction between before versus after COVID-19 pandemic. Cardiovasc Interv Ther. 2022;37:641–50.
Article CAS PubMed PubMed Central Google Scholar
Hammad TA, Parikh M, Tashtish N, Lowry CM, Gorbey D, Forouzandeh F, et al. Impact of COVID-19 pandemic on ST-elevation myocardial infarction in a non-COVID-19 epicenter. Catheter Cardiovasc Interv. 2021;97:208–14.
Erol MK, Kayıkçıoğlu M, Kılıçkap M, Güler A, Yıldırım A, Kahraman F, et al. Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: a nationwide study. Anatol J Cardiol. 2020;24:334–42.
CAS PubMed PubMed Central Google Scholar
Yasuda Y, Ishiguchi H, Ishikura M, Yoshida M, Imoto K, Sonoyama K, et al. Incidence and demographic trends for acute coronary syndrome in a non-epidemic area during the coronavirus disease pandemic in Japan, a 2-institutional observational study. Circ Rep. 2021;3:95–9.
Article PubMed PubMed Central Google Scholar
Yamaji K, Kohsaka S, Inohara T, Numasawa Y, Ando H, Wada H, et al. Percutaneous coronary intervention during the COVID-19 pandemic in Japan: insights from the nationwide registration data. Lancet Reg Health West Pac. 2022;22:100434. https://doi.org/10.1016/j.lanwpc.2022.100434.
Schmitz T, Meisinger C, Kirchberger I, Thilo C, Amann U, Baumeister SE, et al. Impact of COVID-19 pandemic lockdown on myocardial infarction care. Eur J Epidemiol. 2021;36:619–27.
Article CAS PubMed PubMed Central Google Scholar
Chan AW, Kornder J, Elliott H, Brown RI, Dorval JF, Charania J, et al. Improved survival associated with pre-hospital triage strategy in a large regional ST-segment elevation myocardial infarction program. JACC Cardiovasc Interv. 2012;5:1239–46.
Kawakami S, Tahara Y, Noguchi T, Yagi N, Kataoka Y, Asaumi Y, et al. Time to reperfusion in ST-segment elevation myocardial infarction patients with vs. without pre-hospital mobile telemedicine 12-lead electrocardiogram transmission. Circ J. 2016;80:1624–33.
Comments (0)